异动解读 | 阿尔茨海默症药物试验宣布停止,Cassava Sciences Inc盘中暴跌5.47%

异动解读11-26

Cassava Sciences Inc今日盘中股价暴跌5.47%,引发市场关注。

消息显示,这家总部位于德克萨斯州奥斯汀的生物技术公司宣布将停止长期争夺监管部门批准的阿尔茨海默氏症实验药物的高级临床试验。之前该公司一直致力于推进这款阿尔茨海默症新药的审批进程,但如今宣布终止实验显然令投资者失望,加大了市场对公司前景的担忧,导致股价大幅下跌。

阿尔茨海默症疾病一直是医药行业渴望突破的难题,Cassava Sciences宣布放弃此前的努力无疑令市场信心受挫。公司未来能否开发出新的潜在药物将成为投资者关注的焦点。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1139085272?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-26 22:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1139085272","market":"us","top_or_hot":-1,"title":"异动解读 | 阿尔茨海默症药物试验宣布停止,Cassava Sciences Inc盘中暴跌5.47%","media":"异动解读","content":"<p>Cassava Sciences Inc今日盘中股价暴跌5.47%,引发市场关注。</p>\n<p>消息显示,这家总部位于德克萨斯州奥斯汀的生物技术公司宣布将停止长期争夺监管部门批准的阿尔茨海默氏症实验药物的高级临床试验。之前该公司一直致力于推进这款阿尔茨海默症新药的审批进程,但如今宣布终止实验显然令投资者失望,加大了市场对公司前景的担忧,导致股价大幅下跌。</p>\n<p>阿尔茨海默症疾病一直是医药行业渴望突破的难题,Cassava Sciences宣布放弃此前的努力无疑令市场信心受挫。公司未来能否开发出新的潜在药物将成为投资者关注的焦点。</p>","source":"ai_movement_cn","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>异动解读 | 阿尔茨海默症药物试验宣布停止,Cassava Sciences Inc盘中暴跌5.47%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n异动解读 | 阿尔茨海默症药物试验宣布停止,Cassava Sciences Inc盘中暴跌5.47%\n</h2>\n\n<h4 class=\"meta\">\n\n2024-11-26 22:34 北京时间&nbsp;&nbsp;&nbsp;<strong>异动解读</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cassava Sciences Inc今日盘中股价暴跌5.47%,引发市场关注。\n消息显示,这家总部位于德克萨斯州奥斯汀的生物技术公司宣布将停止长期争夺监管部门批准的阿尔茨海默氏症实验药物的高级临床试验。之前该公司一直致力于推进这款阿尔茨海默症新药的审批进程,但如今宣布终止实验显然令投资者失望,加大了市场对公司前景的担忧,导致股价大幅下跌。\n阿尔茨海默症疾病一直是医药行业渴望突破的难题,...</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SAVA","symbol_name":"Cassava Sciences Inc","start_time":0,"source_url":"","article_id":"1139085272","we_media_id":"1092702339","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1139085272","pubTimestamp":1732631694,"columns":[],"sourceInfo":{"source_id":"ai_movement_cn","name":"异动解读"},"weMediaInfo":{"media_name":"异动解读","introduction":"个股异动一手消息解读","home_visible":1,"id":"1092702339","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Cassava Sciences Inc今日盘中股价暴跌5.47%,引发市场关注。\n消息显示,这家总部位于德克萨斯州奥斯汀的生物技术公司宣布将停止长期争夺监管部门批准的阿尔茨海默氏症实验药物的高级临床试验。之前该公司一直致力于推进这款阿尔茨海默症新药的审批进程,但如今宣布终止实验显然令投资者失望,加大了市场对公司前景的担忧,导致股价大幅下跌。\n阿尔茨海默症疾病一直是医药行业渴望突破的难题,Cassava Sciences宣布放弃此前的努力无疑令市场信心受挫。公司未来能否开发出新的潜在药物将成为投资者关注的焦点。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"SAVA":"Cassava Sciences Inc"},"translate_title":"Cassava Sciences Inc plummeted 5.47% intraday interpreting: Alzheimer's drug trial announced suspension","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SAVA":1},"content_text":"Cassava Sciences Inc今日盘中股价暴跌5.47%,引发市场关注。\n消息显示,这家总部位于德克萨斯州奥斯汀的生物技术公司宣布将停止长期争夺监管部门批准的阿尔茨海默氏症实验药物的高级临床试验。之前该公司一直致力于推进这款阿尔茨海默症新药的审批进程,但如今宣布终止实验显然令投资者失望,加大了市场对公司前景的担忧,导致股价大幅下跌。\n阿尔茨海默症疾病一直是医药行业渴望突破的难题,Cassava Sciences宣布放弃此前的努力无疑令市场信心受挫。公司未来能否开发出新的潜在药物将成为投资者关注的焦点。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1139085272"}